Preparation and identification of multifunctional mesoporous silica nanoparticles for invitro and invivo dual-mode imaging, theranostics, and targeted tracking

Biomaterials

Volumn 46, Issue , 2015, Pages 149-158

  Chan, Ming Hsien ^a   Lin, Hsiu Mei ^a  

^a NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

Author keywords

Drug release; Fluorescence; Invitro test; Invivo test; MRI (magnetic resonance imaging); Theranostic

Indexed keywords

CELL MEMBRANES; COVALENT BONDS; DIAGNOSIS; DISEASES; DRUG PRODUCTS; FLUORESCENCE; GRAFTING (CHEMICAL); MAGNETIC RESONANCE IMAGING; MAGNETISM; NANOPARTICLES; RARE EARTH ELEMENTS; SILICA; SILICA NANOPARTICLES; SULFUR COMPOUNDS; TARGETED DRUG DELIVERY; THERANOSTICS;

DRUG RELEASE; IN-VITRO TESTS; IN-VIVO TESTS; MRI (MAGNETIC RESONANCE IMAGING); THERANOSTIC;

CONTROLLED DRUG DELIVERY;

CAMPTOTHECIN; EUROPIUM; FOLIC ACID; GADOLINIUM; GLUTATHIONE; MESOPOROUS SILICA NANOPARTICLE; SILICA NANOPARTICLE; UNCLASSIFIED DRUG; NANOPARTICLE; SILICON DIOXIDE;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CANCER RESEARCH; CELL SURFACE; CELL TRACKING; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DISULFIDE BOND; DOPING; DRUG DELIVERY SYSTEM; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; IMAGING AND DISPLAY; IN VITRO STUDY; IN VIVO STUDY; MAGNETISM; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THERANOSTIC; ANIMAL; BODY WEIGHT; CELL DEATH; DRUG EFFECTS; MULTIMODAL IMAGING; NEOPLASM; PATHOLOGY; POROSITY; ULTRASTRUCTURE; X RAY DIFFRACTION;

ANIMALS; BODY WEIGHT; CAMPTOTHECIN; CELL DEATH; EUROPIUM; GADOLINIUM; HELA CELLS; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MULTIMODAL IMAGING; NANOPARTICLES; NEOPLASMS; POROSITY; SILICON DIOXIDE; X-RAY DIFFRACTION;

EID: 84922796436     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.12.034     Document Type: Article

References (43)

1. Maeda H., Nakamura H., Fang J. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging invivo. Adv Drug Deliv Rev 2013, 65:71-79.
2. Slowing, Vivero-Escoto J.L., Wu C.W., Lin V.S.Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 2008, 60:1278-1288.
3. Tabasi O., Falamaki C., Khalaj Z. Functionalized mesoporous silicon for targeted-drug-delivery. Colloids Surf B 2012, 98:18-25.
4. Xie M., Shi H., Li Z., Shen H.J., Ma K., Li B., et al. Amultifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging. Colloids Surf B 2013, 110:138-147.
5. Argyo C., Weiss V., Brauchle C., Bein T. Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery. Chem Mater 2014, 26:435-451.
6. Lin Y.S., Hurley K.R., Haynes C.L. Critical considerations in the biomedical use of mesoporous silica nanoparticles. JPhys Chem Lett 2012, 3:364-374.
7. Mulder W.J.M., Koole R., Brandwijk R.J., Storm G., Chin P.T.K., Strijkers G.J., et al. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett 2006, 6:1-6.
8. Bruchez M., Moronne M., Gin P., Weiss S., Alivisatos A.P. Semiconductor nanocrystals as fluorescent biological labels. Science 1998, 281:2013-2016.
9. Parak W.J., Gerion D., Pellegrino T., Zanchet D., Micheel C., Williams S.C., et al. Biological applications of colloidal nanocrystals. Nanotechnology 2003, 14:R15-R27.
10. Ow H., Larson D.R., Srivastava M., Baird B.A., Webb W.W., Wiesner U. Bright and stable core-shell fluorescent silica nanoparticles. Nano Lett 2005, 5:113-117.
11. Meiser F., Cortez C., Caruso F. Biofunctionalization of fluorescent rare-earth-doped lanthanum phosphate colloidal nanoparticles. Angew Chem Int Ed 2004, 43:5954-5957.
12. Fu C.C., Lee H.Y., Chen K., Lim T.S., Wu H.Y., Lin P.K., et al. Characterization and application of single fluorescent nanodiamonds as cellular biomarkers. Proc Natl Acad Sci U S A 2007, 104:727-732.
13. Brokmann X., Hermier J.P., Messin G., Desbiolles P., Bouchaud J.P., Dahan M. Statistical aging and nonergodicity in the fluorescence of single nanocrystals. Phys Rev Lett 2003, 90:120601.
14. Shimizu K.T., Neuhauser R.G., Leatherdale C.A., Empedocles S.A., Woo W.K., Bawendi M.G. Blinking statistics in single semiconductor nanocrystal quantum dots. Phys Rev B 2001, 63:205316.
15. Derfus A.M., Chan W.C.W., Bhatia S.N. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004, 4:11-18.
16. Ballou B., Lagerholm B.C., Ernst L.A., Bruchez M.P., Waggoner A.S. Noninvasive imaging of quantum dots in mice. Bioconjugate Chem 2004, 15:79-86.
17. Nam T., Park S., Lee S.Y., Park K., Choi K., Song I.C., et al. Tumor targeting Chitosan nanoparticles for dual-modality Optical/MR Cancer imaging. Bioconjugate Chem 2010, 21:578-582.
18. Zhu L.J., Wang D.L., Wei X., Zhu X.Y., Li J.Q., Tu C.L., et al. Multifunctional pH-sensitive superparamagnetic iron-oxide nanocomposites for targeted drug delivery and MR imaging. JControl Release 2013, 169:228-238.
19. Mondejar S.P., Kovtun A., Epple M. Lanthanide-doped calcium phosphate nanoparticles with high internal crystallinity and with a shell of DNA as fluorescent probes in cell experiments. JMater Chem 2007, 17:4153-4159.
20. Al-Kattan A., Dufour P., Dexpert-Ghys J., Drouet C. Preparation and Physicochemical characteristics of luminescent apatite-based colloids. JPhys Chem C 2010, 114:2918-2924.
21. Tse N.M.K., Kennedy D.F., Kirby N., Moffat B.A., Muir B.W., Caruso R.A., et al. Mesoporous Europo-Gadolinosilicate nanoparticles as bimodal medical imaging agents and a potential theranostic platform. Adv Healthcare Mater 2013, 2:836-845.
22. Lomaestro B.M., Malone M. Glutathione in health and disease: Pharmacotherapeutic issues. Ann Pharmacother 1995, 29:1263-1273.
23. Chapple I.L.C., Brock G., Eftimiadi C., Matthews J.B. Glutathione in gingival crevicular fluid and its relation to local antioxidant capacity in periodontal health and disease. JClin Pathol-Mol Pa 2002, 55:367-373.
24. Meister A., Anderson M.E. Glutathione. Annu Rev Biochem 1983, 52:711-760.
25. Zhang Q., Liu F., Nguyen K.T., Ma X., Wang X.J., Xing B.G., et al. Multifunctional mesoporous silica nanoparticles for cancer-targeted and controlled drug delivery. Adv Funct Mater 2012, 22:5144-5156.
26. Lee J., Kim H., Kim S., Lee H., Kim J., Kim N., et al. Amultifunctional mesoporous nanocontainer with an iron oxide core and a cyclodextrin gatekeeper for an efficient theranostic platform. JMater Chem 2012, 22:14061-14067.
27. Guardado-Alvarez T.M., Devi L.S., Vabre J.M., Pecorelli T.A., Schwartz B.J., Durand J.O., et al. Photo-redox activated drug delivery systems operating under two photon excitation in the near-IR. Nanoscale 2014, 6:4652-4658.
28. Zhang Q., Wang X.L., Li P.Z., Nguyen K.T., Wang X.J., Luo Z., et al. Biocompatible, uniform, and redispersible mesoporous silica nanoparticles for Cancer- targeted drug delivery in. Vivo Adv Funct Mater 2014, 24:2450-2461.
29. Zhou Z.X., Shen Y.Q., Tang J.B., Fan M.H., Van Kirk E.A., Murdoch W.J., et al. Charge-reversal drug conjugate for targeted cancer cell nuclear drug delivery. Adv Funct Mater 2009, 19:3580-3589.
30. Liu Y.M., Feng W.L., Li T.C., He H.Y., Dai W.L., Huang W., et al. Structure and catalytic properties of vanadium oxide supported on mesocellulous silica foams (MCF) for the oxidative dehydrogenation of propane to propylene. JCatal 2006, 239:125-136.
31. Campbell I.G., Jones T.A., Foulkes W.D., Trowsdale J. Folate-binding protein is a marker for ovarian-cancer. Cancer Res 1991, 51:5329-5338.
32. Coney L.R., Tomassetti A., Carayannopoulos L., Frasca V., Kamen B.A., Colnaghi M.I., et al. Cloning of a tumor-associated antigen - Mov18 and Mov19 antibodies recognize a folate-binding protein. Cancer Res 1991, 51:6125-6132.
33. Weitman S.D., Lark R.H., Coney L.R., Fort D.W., Frasca V., Zurawski V.R., et al. Distribution of the folate receptor Gp38 in normal and malignant-cell lines and tissues. Cancer Res 1992, 52:3396-3401.
34. Lu Y.J., Low P.S. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 2002, 54:675-693.
35. Parker N., Turk M.J., Westrick E., Lewis J.D., Low P.S., Leamon C.P. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 2005, 338:284-293.
36. Garcia-Bennett A., Nees M., Fadeel B. In search of the Holy Grail: folate-targeted nanoparticles for cancer therapy. Biochem Pharmacol 2011, 81:976-984.
37. Fan Y., Yang P.P., Huang S.S., Jiang J.H., Lian H.Z., Lin J. Luminescent and mesoporous europium-doped bioactive glasses (MBG) as a drug carrier. JPhys Chem C 2009, 113:7826-7830.
38. Tagaya M., Ikoma T., Yoshioka T., Motozuka S., Minami F., Tanaka J. Efficient synthesis of Eu(III)-containing nanoporous silicas. Mater Lett 2011, 65:2287-2290.
39. Chen F., Huang P., Zhu Y.J., Wu J., Zhang C.L., Cui D.X. The photoluminescence, drug delivery and imaging properties of multifunctional Eu(3+)/Gd(3+) dual-doped hydroxyapatite nanorods. Biomaterials 2011, 32:9031-9039.
40. Ashokan A., Menon D., Nair S., Koyakutty M. Amolecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent. Biomaterials 2010, 31:2606-2616.
41. Sun L., Zang Y., Sun M.D., Wang H.G., Zhu X.J., Xu S.F., et al. Synthesis of magnetic and fluorescent multifunctional hollow silica nanocomposites for live cell imaging. JColloid Interface Sci 2010, 350:90-98.
42. Lin H.M., Lin H.Y., Chan M.H. Preparation, characterization, and invitro evaluation of folate-modified mesoporous bioactive glass for targeted anticancer drug carriers. JMater Chem B 2013, 1:6147-6156.
43. Tang Y., Song H., Su Y., Lv Y. Turn-on persistent luminescence probe based on graphitic carbon nitride for imaging detection of biothiols in biological fluids. Anal Chem 2013, 85:11876-11884.